We are pleased to be joined by a group of voluntary Trustees who govern our work, help determine strategy and provide guidance about how to make living healthy lives easier for all. In addition to quarterly Board meetings, our Trustees also meet regularly for strategy development and finance committee meetings.
You can also find out more about our staff.
Zoe set up ZPB Ltd in August 2009 to help private-, public- and third-sector organisations grow reach and influence in the health sector. She directs many of ZPB’s strategic accounts and has led organisations through major crisis situations, helped reposition well-established brands within the health sector and launched several new organisations into the UK market. She specialises in complex stakeholder engagement and management, content and strategic communications.
Prior to ZPB, Zoe was head of marketing and communications at Dr Foster. During her tenure there, the company trebled in size. Zoe regularly speaks on market access, health tech and how to forge successful cross-sector partnerships, and believes passionately in the role of SMEs in stimulating healthcare innovation and the economy. She manages the Cambridge Health Network, is a fellow of the RSA, and a member of The Entrepreneurs’ Organisation (EOUK). Until recently, she was one of the founder members and treasurer of the Emerging Leaders Network.
Zoe is on the strategy development committee for C3’s Board.
Sally Gilding started her professional career at The Law Commission, an independent body created by statue to keep the application of English law under review. From there, she moved to Clifford Chance, a major international law firm, covering corporate finance and capital markets, before entering the banking industry. Following 18 years at Deutsche Bank, Sally established her own independent business, harnessing her experience and expertise in corporate trust and corporate services.
Sally has held numerous board-level appointments including CEO of a Corporate Trust company and also co-chaired the Women in European Business annual conference. She has been active in corporate social responsibility initiatives supporting Inner London schools. Sally has a law degree from the University of London and a BA in psychology and political science from The Australian National University, Canberra.
Sally is chair of C3’s Board.
John is vice-president of Diabetes UK. Since 2007 John has served on various board committees of the International Diabetes Federation and was a non exec director for 6 years until December 2016. Recently he led the spin out of Changing Health from Newcastle University of Changing Health, the first evidence based education and behaviour change toolkit incorporating digital and telephone based personalised coaching for people with chronic diseases and healthcare professionals.
He is also Managing Director of Metapath, award-winning advisors to stakeholders across the health sector on policy, strategy and delivery of care. John has built a number of consumer centric businesses in the UK and across Europe at including GSK, Carphone Warehouse as well as private equity backed turnarounds. John is a chartered accountant and attended Wharton Business School. He has type 1 diabetes and leads an active lifestyle, including participating in international cycling events.
John is chair of the finance committee for C3’s Board.
Harpreet Sood is a physician currently working on national health-care policy and strategy focused on digital health as a Associate Chief Clinical Information Officer for the NHS. Prior to this, Harpreet was Senior Fellow in the office of the chief executive officer at NHS England. He worked on co-designing and scaling up the National Diabetes Prevention Programme, and co-developed the Five Year Forward View (2014).
His passion lies in public health and disease prevention, particularly in how the latest advances in technology, data availability and digital health can improve population and public health on a system level – and he has worked for digital health start-ups, including co-founding Mighty Lungs (a video game to improve children’s adherence of preventative asthma medication). Harpreet holds a Masters in Public Health from Harvard University and has previously been a fellow in administration and health policy at Brigham and Women’s Hospital in Boston. Harpreet sits on the NHS Prevention Board and is Vice Chair for British Computer Society (Health).
Harpreet is on the finance committee for C3’s Board.
Caroline joined Bupa in February 2013 from a long career in the National Health Service. She has a clinical background and brings considerable experience of working at both national (UK) and regional level to enhance and develop leadership capability across health systems. Her position – as director of clinical leadership – recognises that the performance of Bupa as a leading global healthcare company, and the delivery of its ambitious goals enshrined in Bupa 2020, will, in part, be dependent on positioning clinicians at the heart of shaping, influencing and running all elements of the business.
Working in the context of the emerging leadership strategy for Bupa, Caroline’s role is to be the catalyst for enabling connecting and uniting the clinical community to make the biggest possible contribution towards Bupa’s purpose – ‘Longer, Healthier, Happier Lives’.
Professor Tracey Pérez Koehlmoos, PhD, MHA is a health systems and policy scientist who specialises in leading complex tasks, program development and capacity building across the spectrum of health systems building blocks. She currently leads a robust health services and policy research program and the PhD in public health program in support of the US Military Health System at the Uniformed Services University of the Health Sciences.
Previously she served as the Special Assistant to the Assistant Commandant of the Marine Corps. She has more than 150 publications and multimedia products. Prior to transitioning to domestic and defense healthcare, she lived and worked in Saudi Arabia, Pakistan, Nepal, Bangladesh and Indonesia. She cut her teeth in public health leading the Health & Family Planning Systems Programme at ICDDR,B in Dhaka Bangladesh. There, she scaled up zinc for the treatment of childhood diarrhea; founded the Centre for Control of Chronic Diseases and created and led the Centre for Systematic Review, which focuses on health systems and policy issues in low- and middle-income countries and conducted capacity building in this methodology across South Asia.
Susan Jobling is a Professor of Environmental Toxicology and Director of a Research Institute of Environment, Health and Societies at Brunel University London with over 25 year’s experience in her field. Her research focus is understanding how environmental pollutants impact the health of humans and wildlife and her highly cited published works has had societal impact worldwide in guiding the risk assessment and regulation of chemicals.
As Founder and Director of the Institute of Environment, Health and Societies, Susan provides strategic leadership of environmental and health-related research that contributes to the creation and development of sustainable, secure and healthy societies. The Institutes mission is to carry out fundamental and applied research that will improve our environments, health and wellbeing and promote social justice. Susan holds several Advisory Board appointments, is a Director of a gene therapy spinout company, Trustee of a patient advocacy charity for Alk-positive lung cancer and Founder of Breathe for Life, a community cycle relay across the British Isles to raise awareness of rising numbers of women and men with non-smoking lung cancers and of air pollution as an under-recognised risk factor.